12 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
algorithms by Global ... Chronic Obstructive Lung ... LAMA: long-acting ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
(LAMA) can be added ... Respimat is the only LAMA ... nonpharmacologic management ... before increasing medication ... Stepwise #Therapy #Management
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
overlap; ICS = ... -agonist; LAMA = ... #Diagnosis #Management ... #Differences #Algorithm ... #Treatment
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
(GINA) treatment ... receptor antagonists; LABA ... : long-acting β2 ... #GINA #Asthma #Management ... #Algorithm #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... of expiration; ICS ... , long-acting β2 ... -agonist; LAMA, ... #Algorithm #Management
COPD Preferred Treatments - GOLD 2018 

COPD is a common progressive respiratory condition that can be
COPD Preferred Treatments ... Management of COPD ... LAMA/LABA/ICS. ... GOLD2018 #COPD #Treatment ... #Management
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Commonly used in Asthma ... powder into their lungs ... posts for the COPD treatment ... algorithm).
Assessment and Treatment of Severe Asthma, According to Inflammatory Phenotypes, in Patients without a Response to
Assessment and Treatment ... of Severe Asthma ... of at least 30 IU ... #Management #PCC ... #Algorithm #Phenotypes
Stepwise approach for managing asthma in youths greater than 12 years of age and adults as
environmental control and management ... are as follows: ICS ... (long-acting β2 ... 152(4):232-7 #Management ... #Therapy #LABA
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... lung disease (ILD ... SSc #pulmonary #indications ... #management #treatment ... #algorithm